DrugDashboards

Fleet

sodium phosphate, dibasic and sodium phosphate, monobasic · SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 7 g/118mL; SODIUM PHOSPHATE, MONOBASIC 19 g/118mL · Enema · Rectal · C.B. Fleet Company, Inc.

NDC 00132-0201-40 · 133 mL in 1 BOTTLE, WITH APPLICATOR · OTC MONOGRAPH DRUG · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price is up 16% over the past year, to $0.0095 per mL. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.005$0.01Sep 2013Sep 2026$0.0095
42 price points · per ML · held since Invalid DateSource: CMS NADAC

Medicaid spend (2025)

$307,376
24,419 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

30Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for sodium phosphate, dibasic and sodium phosphate, monobasic (other) in the next 90 days

price up 16% YoY · sole-source market · 1 Class I/II recall(s) in 12 months

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
M007
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of sodium phosphate, dibasic and sodium phosphate, monobasic (Enema)

LabelerStrengthFirst seenLast seen
C.B. Fleet Company, Inc.SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 3.5 g/66mL; SODIUM PHOSPHATE, MONOBASIC 9.5 g/66mLJul 15, 2026Sep 2, 2026
C.B. Fleet Company, Inc.SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 7 g/118mL; SODIUM PHOSPHATE, MONOBASIC 19 g/118mLJul 15, 2026Sep 2, 2026
C.B. Fleet Company, Inc.SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 7 g/230mL; SODIUM PHOSPHATE, MONOBASIC 19 g/230mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Fleet — NDC 00132-0201-40," retrieved September 3, 2026, https://drugdashboards.com/drug/00132020140.

Free to cite with attribution — see how the data is put together.